Stockscreener 앱 받기
1.21
4.72%
-0.06
시간 외 거래:
1.22
0.01
+0.83%
iBio Inc 주식(IBIO)의 최신 뉴스
Why iBio Inc. (0JV0) stock could be next leader2025 Big Picture & Free Daily Entry Point Trade Alerts - newser.com
How buybacks impact iBio Inc. stock valueWeekly Market Outlook & Safe Entry Trade Signal Reports - newser.com
Why iBio Inc. stock is rated strong buy2025 Technical Patterns & Risk Controlled Daily Trade Plans - newser.com
Is iBio Inc. stock attractive for long term wealth building2025 Price Action Summary & Weekly High Return Forecasts - newser.com
iBio Inc. stock retracement – recovery analysisJuly 2025 Pullbacks & Long-Term Growth Plans - newser.com
Risk vs reward if holding onto iBio Inc.2025 Fundamental Recap & High Accuracy Swing Trade Signals - newser.com
Analyzing iBio Inc. with multi timeframe chartsMarket Sentiment Report & Technical Pattern Alert System - newser.com
Real time pattern detection on iBio Inc. stock2025 Technical Overview & Weekly High Return Stock Forecasts - newser.com
iBio (IBIO) Gains Attention with Promising Obesity Treatment - GuruFocus
Biotech Alert: Searches spiking for these stocks today - TipRanks
Does iBio Inc. (0JV0) stock trade below intrinsic value2025 Fundamental Recap & Free Fast Entry Momentum Trade Alerts - newser.com
iBio (IBIO) Gains Positive Outlook with Analyst Coverage and Inn - GuruFocus
Is IBIO Stock On The Verge Of A Breakthrough? - StocksToTrade
iBio Surges: Big Moves on the Horizon? - timothysykes.com
iBio to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference - The Manila Times
iBio (NASDAQ: IBIO) fireside chat Nov 10 at 8:30 a.m. ET on obesity pipeline, Guggenheim - Stock Titan
Why Did iBio Shares Surge Over 11% In Pre-Market Trading? - Benzinga
IBIO insider Form 4: CFO awarded 75,000 options, vesting over 3 years - Stock Titan
Form 4: iBio awards 55,000 options to Chief Legal Officer - Stock Titan
What analysts say about iBio Inc 0JV0 stockGrowth vs. Value Investing & Exceptional Return Investment - earlytimes.in
iBio (IBIO) Gains Attention with Innovative Drug Development - GuruFocus
Ibio Inc. sell Wolf_of_WS - sharewise.com
iBio initiated with an Outperform at Oppenheimer - MSN
Key resistance and support levels for iBio Inc.July 2025 Momentum & Low Risk High Reward Trade Ideas - newser.com
IBIO Stocks Skyrocket: An In-Depth Overview - StocksToTrade
US Stocks Mixed; Coca-Cola Posts Upbeat Earnings - Benzinga
This ACADIA Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Oppenheimer Initiates Coverage of iBio (IBIO) with Outperform Recommendation - Nasdaq
iBio Stock Surges on Bullish Analyst Calls and Obesity Drug Breakthroughs - ts2.tech
Oppenheimer Initiates Coverage on iBio With Outperform Rating, $5 Price Target - MarketScreener
iBio to Present New Preclinical Data on Its Activin E Antibody at Two Upcoming Scientific Conferences, ObesityWeek® and PEGS Europe 2025 - The Manila Times
Oppenheimer Initiates Coverage on IBIO with an Outperform Rating - GuruFocus
Why Crown Holdings Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Is iBio Inc. (0JV0) stock worth holding before Fed meetingGap Down & Weekly Watchlist for Hot Stocks - newser.com
1.11%
0.29%
자본화:
|
볼륨(24시간):